Background: Neurologic complications of endocarditis can influence diagnosis, therapeutic plans, and prognosis.
I
nfective endocarditis (IE) is a rare but severe disease with an in-hospital mortality rate of approximately 20% and 5-year mortality rate of 40% (1) (2) (3) . Neurologic complications of IE contribute to its poor prognosis (4 -6) . Clinically symptomatic neurologic complications, reported in 20% to 40% of patients with acute IE, consist of ischemic stroke and transient ischemic attack, hemorrhagic stroke, mycotic aneurysms, and abscesses (4 -6) . Neurologic complications may influence the management of patients with acute IE in several ways. Their presence can facilitate diagnosis because, as peripheral manifestations of IE, they are minor criteria in the Duke classification. They can also affect medical therapy (for example, by changing the type and length of antibiotic or anticoagulant therapy). In addition, a diagnosis of embolism in a patient with a large vegetation may lead to urgent valvular surgery during the acute phase of IE to prevent the recurrence of embolism. Alternatively, cerebral bleeding is a transient contraindication for surgery. Systematic cerebral imaging reveals that as many as 30% of patients have silent neurologic complications (7, 8) . Some studies (9, 10) suggest using systematic computed tomography (CT) to thoroughly search for asymptomatic embolisms. Magnetic resonance imaging (MRI) is a better tolerated and more sensitive and specific method of detecting brain abnormalities (11) . Only 2 recent studies (7, 12) have analyzed the use of MRI in patients with acute IE (in 40 and 49 patients, respectively), but neither addressed the consequences of MRI findings for diagnosis and decision making.
Despite several supporting arguments, current guidelines (13, 14) do not explicitly recommend systematic use of cerebral imaging during acute IE, probably because its effect on management of patients with acute IE has not yet been evaluated. Because of the rarity, highly polymorphic presentation, and large number of prognostic variables of IE, randomized clinical trials are particularly difficult to perform. In this context, we chose to assess whether early cerebral MRI affects the diagnosis and the management of hospitalized adults with IE (15) .
METHODS

Design and Patients
We conducted the IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) study, a prospective, single tertiary care medical center study, between 1 June 2005 and 30 October 2008. We included consecutive patients who had definite or possible acute IE according to the Duke-modified criteria. We also included patients who did not fulfill the criteria for definite or possible IE at that time (IE excluded) if they had no other confirmed diagnosis and suspicion of IE was sufficient to warrant initiation of IE antimicrobials. Exclusion criteria were the usual contraindications to MRI, previous cerebral MRI during the ongoing episode of IE, and urgent need for surgery. The local ethics committee approved the study. All patients gave written informed consent.
Measurements and MRI Interpretation
All patients had a clinical examination that included a detailed standardized neurologic examination and a standard examination of skin and mucosa, looking in particular for Osler nodes. All patients received transthoracic or transesophageal echocardiography as clinically indicated at inclusion, by using a standardized procedure. We assessed valvular regurgitation semiquantitatively on a scale of 0 to 4. We measured vegetation length in multiple views and retained the largest measurement. We categorized vegetation mobility as previously described (16) and considered it severe if the vegetation prolapsed across the coaptation plane of the affected valve. If we found multiple vegetations, we evaluated the largest vegetation. We defined an abscess as a thickened area or mass with a heterogeneous echogenic or echolucent appearance.
All patients had repeated blood cultures, and those with negative cultures had serologic tests for microorganisms responsible for IE. When possible, patients had a funduscopic examination and were checked for glomerulonephritis and a positive Latex-Waler-Rose result before MRI.
We performed MRI scans on a single 1.5-T GE system (GE Healthcare, Chalfont St. Giles, United Kingdom). Scans had to be performed within 7 days after inclusion, before any surgical intervention, by using a standardized protocol that included b1000 diffusion, T2* gradient recalled imaging, T2 fluid-attenuated inversion recovery (FLAIR)-weighted sequences, 3-dimensional T1 postcontrast (Dotarem, Guerbet, France) with a 5-mm slice thickness and 0.5-mm slice gap, and magnetic resonance angiography. Two neuroradiologists independently interpreted the 60 initial MRI scans by using a standardized reporting form to assess inter-neuroradiologist agreement. Further scans were interpreted by 1 member of a panel of 3 neuroradiologists. All neuroradiologists were blinded to patient characteristics.
We collected data on recent and old ischemic lesions, parenchymal hemorrhage, subarachnoid hemorrhage, brain abscess, microhemorrhages, and aneurysms. We assessed the number, size, and location of brain lesions. We defined acute stroke as a hyperintense infarct with restricted apparent diffusion on diffusion-weighted images. For infarct size, we distinguished large territorial infarcts (infarction of a large arterial cortical or subcortical territory secondary to a proximal cerebral artery occlusion) from small cortical and subcortical lesions. Hemorrhagic lesions comprised acute and chronic parenchymal and pericerebral bleeding, detected on T2* gradient-recalled and FLAIR sequences. We defined microhemorrhages as round T2* hypointensities with a diameter of 10 mm or less, as previously described (17, 18) . We defined cerebral abscesses as round expansive lesions with central restricted apparent diffusion, hyperintense peripheral edema on FLAIR sequence, and postcontrast annular enhancement. We defined mycotic aneurysms as focal saccular or fusiform enlargement of an intracranial artery on time-of-flight-weighted and contrastenhanced magnetic resonance angiography sequences and 3-dimensional T1-weighted sequences. We considered saccular aneurysms located on the circle of Willis to be congenital aneurysms. We clinically assessed adverse events related to MRI during the 7 days after MRI. Events had to be declared to the sponsor within 48 hours, according to our protocol.
Assessment of Changes in Diagnosis and Management
Two experts in IE, including a cardiologist and an infectious disease specialist, examined the patients within 24 hours before MRI and completed a standardized questionnaire concerning IE characteristics and the presence of neurologic complications. They jointly established an initial IE diagnostic classification according to the modified
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Article Infective Endocarditis and Early Cerebral MRI Duke criteria and outlined an antimicrobial therapy plan and, if necessary, a surgery plan that included timeline, type of surgery, and indications. Within 24 hours after MRI, the same experts jointly reclassified their diagnosis of IE and proposed diagnostic or therapeutic modifications as appropriate on the basis of the results. We established a final Duke classification at discharge that took the occurrence of new events and the results of surgery (microbiology or histology) into account.
Clinical Follow-up
We performed 6-month follow-up by telephone call to the patient or the referring physician to assess vital status, the performance of valvular surgery, recurrence of IE, and occurrence of new neurologic events.
Statistical Analysis
On the basis of studies that used systematic CT scan and autopsy studies on IE, we hypothesized that MRI would detect IE-related abnormalities in 20% of patients and lead to modification of the IE Duke classification or therapeutic plans in 75% of those cases. We therefore expected that MRI would cause modifications of diagnostic or therapeutic plans in 15% of patients. Including 150 patients would allow us to estimate this frequency with a 95% CI of 12 percentage points (for example, 9 to 21). We present characteristics as proportions or as means (SDs). We assessed interobserver concordance of the analysis of the 60 initial cerebral MRIs by using the coefficient. We used the binomial distribution to calculate exact CIs for proportions and statistics.
Role of the Funding Source
The French Ministry of Health provided funding for the study. The funding sources had no role in the study design, implementation, or analysis of the data.
RESULTS
Study Sample
Of the 274 consecutive patients hospitalized for IE at Bichat-Claude Bernard Hospital, Paris, France, between 1 June 2005 and 30 October 2008, 150 were included in the IMAGE study. Figure 1 details the reasons for exclusion. In 9 patients, MRI was either not performed or blurred because the patient moved. In 11 other patients, we ultimately excluded IE and prematurely interrupted the antibiotic therapy that had been initiated when we suspected IE. Four of these 11 patients had valvular surgery, which provided no micro-or macroscopic data that confirmed IE. Figure 1 shows the diagnoses each of these patients received at discharge.
Of the 130 remaining patients (93 men and 37 women), 77 (59%) were classified as having definite IE and 50 (38%) as having possible IE, and IE was excluded in 3 (2%) at inclusion. Table 1 shows patient characteristics. One hundred twenty-one patients (93%) had transesophageal echocardiography. In 37 patients (28%), IE developed on a cardiac prosthesis. Sixteen (12%) had neurologic abnormalities 
Patient Characteristics
MRI Results
No adverse event related to MRI occurred. Interobserver concordance of the analysis of cerebral MRI was high, with a coefficient of 0.89 (95% CI (Figures 2 to 4) . Meningeal hemorrhage was detected in 11 patients (8%). In 10 patients (8%), MRI indicated a mycotic aneurysm; 6 of these patients had cerebral arteriography, which confirmed aneurysm in 4. Among the 10 patients with exclusive right-sided IE, 3 had abnormal MRI results, which revealed large ischemic lesions in 1 and the coexistence of small ischemic lesions and microhemorrhages in 2. Two of these 3 patients had transesophageal echocardiography, which indicated a patent foramen ovale; the third patient had only transthoracic echocardiography without contrast.
Changes in Diagnostic Classification
Excluding cerebral microhemorrhagic lesions, which are currently not included as vascular phenomena in the Duke-modified classification, we increased the number of * Refers to infarction of a large arterial cortical or subcortical territory secondary to a proximal cerebral artery occlusion.
Article Infective Endocarditis and Early Cerebral MRI minor Duke-modified criteria met by 50 of the 130 patients (38%) on the basis of MRI results. For 17 of these 50 patients (34%; 13% of the 130 study patients and 32% of the 53 patients with nondefinite IE at inclusion), we upgraded the diagnosis of IE from possible to definite (14 patients) or excluded the diagnosis to possible (3 patients) because of the additional criteria met ( Table 3) . For the 3 patients in whom we initially excluded IE, we could have upgraded the diagnosis to possible IE on the basis of clinical evolution even without considering MRI results. When we included microhemorrhages as vascular phenomena in the Duke classification, we upgraded the diagnosis of IE in 27 patients (51% of the 53 nondefinite IE) on the basis of MRI results, with 24 patients upgraded from possible to definite IE and 3 upgraded from excluded to possible IE. We increased the number of criteria met on the basis of MRI results only. At discharge, we classified 105 patients as having definite IE and 25 as having possible IE, regardless of MRI results (Figure 1) .
Changes in Clinical Decisions
Excluding microhemorrhages, we modified IE treatment solely on the basis of MRI results for 24 patients (18%), changing only anticoagulation treatment for 1, only antimicrobial therapy for 5, and surgery plan with or without other modifications for 18. Surgery plan modifications comprised changing the surgery date (12 patients; 6 postponements and 6 advancements), modifying the type of valvular prosthesis (1 patient), changing reasons for surgery (1 patient), cancelling surgery (2 patients), and deciding to operate (2 patients). For 3 patients, we modified the surgery plan along with the antimicrobial or anticoagulant therapy plan. In 3 patients, surgery was preceded by embolization of a silent aneurysm. Including microhemorrhages, we modified therapeutic plans for 5 additional patients, modifying anticoagulation treatment for all.
Excluding microhemorrhages, we upgraded the IE Duke classification or modified treatment options for 36 of the 130 patients (28% [CI, 20% to 36%]) on the basis of MRI results.
In-hospital Outcome and Follow-up
Sixty patients (46%) had valve surgery before hospital discharge, 41 on a native valve and 19 on a prosthetic valve. None of these patients had reoperation within 6 months. Three additional patients had surgery on a native valve between hospital discharge and 6 months.
We obtained 6-month follow-up for 127 patients (98%), by direct telephone calls for 120 of the patients and calls to the referring physician for 7. We lost 3 patients to follow-up because they moved, 2 of them to a foreign country. Twenty patients (15%) died at 6 months, 15 during hospitalization and 5 after discharge. Of the patients who had surgery, 3 died of multiorgan failure, 2 of low cardiac output, 1 of septic shock, and 1 of bleeding. Of those who did not have surgery, 4 died of hemodynamic causes, 3 of multiorgan failure, 3 of neurologic causes, and 3 of cancer. Table 4 details the relationship between cerebral MRI findings and 6-month outcome. During follow-up, 3 patients died of neurologic manifestations that developed during hospitalization; all had been neurologically asymptomatic at the time of MRI but had abnormal MRI findings. One patient, whose MRI showed only small ischemic lesions, experienced an ischemic stroke at day 50; a second patient, whose MRI showed only small ischemic lesions, experienced a hemorrhagic transformation at day 16. The third patient, whose MRI showed only microhemorrhages, died of an ischemic stroke at day 23. No patient experienced a neurologic event between discharge and 6 months.
DISCUSSION
Our study, which evaluated changes in diagnostic classifications or clinical decisions due to MRI findings in 130 patients at the early phase of IE, shows that MRI revealed possible IE-related lesions in most patients with (82%) and without (79%) neurologic symptoms. Even without considering microhemorrhages, which are recently identified IE-associated lesions (19) , cerebral MRI findings still led to changes in diagnostic classification or clinical decisions for 28% of the patients.
Studies that used systematic CT (8, 10, 16) have shown that the central nervous system is more frequently involved in patients with IE than neurologic symptoms would suggest. Using a MEDLINE search up to August 2009, we identified only 2 English-language prospective studies (7, 12) that used cerebral MRI in patients with IE (in 40 and 49 patients, respectively). These studies reported respective rates of 80% and 65% for clinical or asymptomatic cerebral lesions. However, 1 team of investigators (7) did not perform diffusion-weighted images. Autopsies performed in the 1960s revealed brain lesions in up to 90% of patients (20) . The rate of cerebral lesions that we observed by using highly sensitive MRI sequences with angiography is consistent with previous data.
Although MRI also detected asymptomatic lesions known to be associated with IE (ischemic strokes and ab- scesses), the most frequently detected lesions were microhemorrhages, which were present in almost two thirds of patients. These lesions were previously identified in elderly patients with cerebral microangiopathy secondary to chronic hypertension or amyloid angiopathy (21, 22). They have been recently reported in the population with IE (23, 24) and are much more frequent in this population than in age-and sex-matched patients without IE (19) . In patients with IE, microhemorrhages may reflect a subacute microvascular process that could be due to immunologic vasculitis or an embolic process in vasa vasorum. However, microhemorrhages are not currently included as vascular phenomena in the Duke modified classification. Previous studies that used brain CT or MRI in acute endocarditis (7, 12) were not designed to assess the changes in diagnostic classification and clinical management due to MRI. Our discovery of silent neurologic lesions was of both iconographic and clinical interest, because it led to the early (within the first week) modification of initial IE diagnostic classification. This was of greater importance for patients with nondefinite IE early in their treatment, for whom MRI results produced early confirmation of the IE diagnosis according to the Duke criteria. The Duke criteria classification we performed at discharge, which took all events that occurred during the IE episode into account (including microbiologic culture and histologic examination of the valve when surgery was performed), confirmed diagnostic classification changes for all patients. This shows that MRI led to earlier modification than the usual patient follow-up. These neurologic lesions also led us to modify IE therapeutic plans by embolizing or closely following silent aneurysms and rescheduling cardiac surgery, which we postponed for patients suspected to be at high risk for cerebral bleeding and advanced for those considered to be at high risk for reembolization.
Our study has limitations. First, we did not assess whether changes in diagnostic classifications and therapeutic plans due to MRI findings affected patient prognosis or outcomes. We also did not examine the costs or potential harms of performing MRI for all patients, such as falsepositive findings, unnecessary work-ups, or unnecessary procedures or surgery. Second, because we aimed to quantify the changes due to MRI findings, we did not include the 18 patients who previously had MRI for the current episode. Of these, 16 had had MRI because they had neurologic manifestations. This could explain the relatively low rate and severity of symptomatic neurologic complications in our study. Third, we excluded some patients (17%) because they needed emergency cardiac surgery, the urgent nature of which precluded anything but vital clinical action. Fourth, we conducted our study in a tertiary care hospital that accepts many patients with IE. Whether our results could be extrapolated to hospitals that are less experienced in IE management remains to be determined. Finally, our objective (to assess the effect of MRI) may have influenced our evaluation of the changes in clinical management decisions due to MRI findings.
Our prospective study shows that early MRI identified cerebral lesions in many patients with IE who did not have neurologic symptoms. These findings also affected expert diagnostic classifications and clinical management plans. Additional studies are needed to assess whether MRI improves patient outcomes or leads to unnecessary procedures and increased costs. 
